Is ANGN or DIVO a better dividend investment in 2026?

ANGN currently yields 200.00% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: ANGN offers higher current income.

What is the dividend yield difference between ANGN and DIVO?

ANGN has a forward dividend yield of 200.00% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 193.51 percentage points.

Home › Compare › ANGN vs DIVO

ANGN vs DIVO: Dividend Comparison 2026

ANGN yields 200.00% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ANGN wins by $119.33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ANGN

● Live price

200.00%

Share price

$1.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$119.36M

Annual income

$60,176,096.29

Full ANGN calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — ANGN vs DIVO

📍 ANGN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ANGN	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ANGN + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ANGN pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANGN

Annual income on $10K today (after 15% tax)

$17,000.00/yr

After 10yr DRIP, annual income (after tax)

$51,149,681.85/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, ANGN beats the other by $51,148,847.42/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANGN + DIVO for your $10,000?

ANGN: 50%DIVO: 50%

100% DIVO50/50100% ANGN

Portfolio after 10yr

$59.70M

Annual income

$30,088,538.98/yr

Blended yield

50.40%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ANGN right now

ANGN

Analyst Ratings

Buy

Hold

Consensus: Hold

Price Target

$1.50

+50.0% upside vs current

Range: $1.50 — $1.50

Altman Z

-16.3

Piotroski

3/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANGN buys

DIVO buys

No recent congressional trades found for ANGN or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricANGNDIVO

Forward yield	200.00% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$119.36M ✓	$30.7K
Annual income after 10y	$60,176,096.29 ✓	$981.68
Total dividends collected	$112.49M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ANGN vs DIVO ($10,000, DRIP)

Year	ANGN Portfolio	ANGN Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$30,700	$20,000.00	$11,349	$649.42	+$19.4K → ANGN
2	$90,232	$57,383.18	$12,833	$688.83	+$77.4K → ANGN
3	$254,173	$157,624.56	$14,459	$727.90	+$239.7K → ANGN
4	$686,927	$414,961.74	$16,238	$766.49	+$670.7K → ANGN
5	$1,783,118	$1,048,106.39	$18,179	$804.47	+$1.76M → ANGN
6	$4,450,613	$2,542,677.12	$20,293	$841.71	+$4.43M → ANGN
7	$10,693,420	$5,931,263.38	$22,591	$878.14	+$10.67M → ANGN
8	$24,760,608	$13,318,648.86	$25,087	$913.65	+$24.74M → ANGN
9	$55,315,649	$28,821,798.66	$27,791	$948.18	+$55.29M → ANGN
10	$119,363,841	$60,176,096.29	$30,718	$981.68	+$119.33M → ANGN

ANGN vs DIVO: Complete Analysis 2026

ANGN — Stock

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.

Full ANGN Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this ANGN vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANGN vs SCHD ANGN vs JEPI ANGN vs O ANGN vs KO ANGN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.